Atlas Trials

Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure

Clinical trial NCT01543854 · COMPLETED

Trial details

NCT number
NCT01543854
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Heart Failure
Start date
2012-03-01
Primary completion
2013-01-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.